Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P20226 (
TATA-binding protein
)
1,297
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Earlier reports show that p53, both wild type and mutants, may affect transcription. Wild-type p53 activates promoters with p53-binding sites while inhibiting promoters without binding sites. Mutant p53, on the other hand, has been shown to activate transcription from specific promoters. These observations suggest that both wild-type and mutant p53 may interact with a general transcription factor(s). In this report, we have shown that the cloned
TATA-binding protein
(
TBP
) from human and yeast interacts with human p53.
TBP
co-immunoprecipitates with wild-type or mutant human p53 when incubated with the p53-specific monoclonal antibody and
Protein A
-agarose. Wild-type murine p53 has also been found to interact with human
TBP
. Protein blot assays have demonstrated that the interaction between p53 and human
TBP
is direct. By gel retention analysis, we have shown that the complex of
TBP
and p53 (both wild type and mutant) can bind to the TATA box. The similar qualitative binding capability of wild-type and mutant p53 with human
TBP
and the similarity of the two complexes in binding to the TATA box suggest that the functional discrimination between wild-type and mutant p53 may not lie in their ability to bind
TBP
. The nature of the p53.
TBP
or p53.
TBP
.TATA complex may determine the success of transcription.
...
PMID:p53 binds to the TATA-binding protein-TATA complex. 851 46